Style | Citing Format |
---|---|
MLA | Noorbakhsh S, et al.. "Lessons From Ten Years’ the Prevalence of Congenital Rubella Syndrome (Crs) in the Young Population Living in a Developing Country, Tehran; Iran." Infectious Disorders - Drug Targets, vol. 22, no. 3, 2022, pp. -. |
APA | Noorbakhsh S, Vafaeeshahi M, Tahernia L, Ashouri S, Riahi A (2022). Lessons From Ten Years’ the Prevalence of Congenital Rubella Syndrome (Crs) in the Young Population Living in a Developing Country, Tehran; Iran. Infectious Disorders - Drug Targets, 22(3), -. |
Chicago | Noorbakhsh S, Vafaeeshahi M, Tahernia L, Ashouri S, Riahi A. "Lessons From Ten Years’ the Prevalence of Congenital Rubella Syndrome (Crs) in the Young Population Living in a Developing Country, Tehran; Iran." Infectious Disorders - Drug Targets 22, no. 3 (2022): -. |
Harvard | Noorbakhsh S et al. (2022) 'Lessons From Ten Years’ the Prevalence of Congenital Rubella Syndrome (Crs) in the Young Population Living in a Developing Country, Tehran; Iran', Infectious Disorders - Drug Targets, 22(3), pp. -. |
Vancouver | Noorbakhsh S, Vafaeeshahi M, Tahernia L, Ashouri S, Riahi A. Lessons From Ten Years’ the Prevalence of Congenital Rubella Syndrome (Crs) in the Young Population Living in a Developing Country, Tehran; Iran. Infectious Disorders - Drug Targets. 2022;22(3):-. |
BibTex | @article{ author = {Noorbakhsh S and Vafaeeshahi M and Tahernia L and Ashouri S and Riahi A}, title = {Lessons From Ten Years’ the Prevalence of Congenital Rubella Syndrome (Crs) in the Young Population Living in a Developing Country, Tehran; Iran}, journal = {Infectious Disorders - Drug Targets}, volume = {22}, number = {3}, pages = {-}, year = {2022} } |
RIS | TY - JOUR AU - Noorbakhsh S AU - Vafaeeshahi M AU - Tahernia L AU - Ashouri S AU - Riahi A TI - Lessons From Ten Years’ the Prevalence of Congenital Rubella Syndrome (Crs) in the Young Population Living in a Developing Country, Tehran; Iran JO - Infectious Disorders - Drug Targets VL - 22 IS - 3 SP - EP - PY - 2022 ER - |